药物对比
Canagliflozin vs Tolbutamide
比较口服药物Canagliflozin与Tolbutamide治疗2型糖尿病。SGLT2抑制剂与磺脲类：作用、获益及风险方面的主要差异。
此页面暂无可用的对比维度。
临床背景
This comparison arises for type 2 diabetes patients considering newer SGLT2 inhibitors over older first-generation sulfonylureas.
结论
Canagliflozin generally offers more benefits than Tolbutamide for most eligible type 2 diabetes patients.
全部药物对比